NVO

Novo Nordisk A/S $43.45 1M -7.0% 3M -1.0% YTD -17.1% as of 2026-09-14
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.0%
Next 1 week
-0.0%
Next 1 month
-0.2%
Seasonality
Mildly positive window
Next 30 days (to Oct 15): +1.2% median, 57% of the last 44 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 34
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.03%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.12 -0.5% · Seasonal tilt +0.3%
$193.6B market cap (#17 US) $485M/day volume 46% volatility -20% 1-year -71% from ATH
52-week range · 29% of the way up · -32% from the high
$35.12$64.16

Congressional trades in NVO Full tracker →

15 members · 19 buys / 15 sells · $452K–$1.3M disclosed · latest filing Jul 21, 2026.

BUY AA Alan Armstrong · traded Mar 30, 2026 $15K–$50K
SELL LM Lisa McClain · traded Oct 31, 2025 $1K–$15K
SELL LM Lisa McClain · traded Oct 30, 2025 $1K–$15K
BUY LM Lisa McClain · traded Oct 30, 2025 $1K–$15K
BUY LM Lisa McClain · traded Sep 11, 2025 $1K–$15K
BUY MG Marjorie Taylor Greene · traded Oct 15, 2025 $1K–$15K
BUY VH Valerie Hoyle · traded Oct 29, 2024 $1K–$15K
SELL LM Lisa McClain · traded Aug 4, 2025 $1K–$15K

Earnings Full history →

Next report 2026-11-04 (Wednesday, before open, in 50 days) · EPS est. 5.11.

1-day std dev
5.1%
Finished up
44%
Biggest pop
+8.3%
Biggest drop
-12.9%

Standard deviation of the close-to-close move over the last 45 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.